Study of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Feb 27, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • SGM (as per self-report) palliative care patients identified through Memorial Sloan Kettering Cancer Center's Palliative Care team and primary solid tumor oncology clinics.
- • Age 18 and older (as per self-report/EHR)
- • English-speaking as per the English language assessment items below and wil ing to receive the intervention in English.
- • o What is the participant's preferred language?
- • (Specify Lang)___________________________
- • How well does the participant speak English?
- • Very well (PARTICIPANT IS ELIGIBLE)
- • Well (PARTICIPANT is ELIGIBLE)
- • Not well (PARTICIPANT is NOT ELIGIBLE)
- • Not at all (PARTICIPANT is NOT ELIGIBLE)
- Exclusion Criteria:
- • Delirium/ altered mental status prohibitive of providing consent.
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Montvale, New Jersey, United States
Uniondale, New York, United States
Harrison, New York, United States
Basking Ridge, New Jersey, United States
Middletown, New Jersey, United States
Commack, New York, United States
Patients applied
Trial Officials
William E Rosa, Ph.D., MBE, NP
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported